We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NHTC:NASDAQNatural Health Trends Corp. - Commn Stock Analysis

Data as of 2026-04-20 - not real-time

$2.99

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Natural Health Trends Corp. trades around $2.99, with the 20‑day SMA (~$2.83) sitting below the current price, while the 50‑day and 200‑day SMAs remain higher, signaling a short‑term bearish bias. Technical momentum is mixed: the RSI hovers near 54, suggesting neutral pressure; the MACD histogram turned positive, offering a modest bullish hint, yet the overall trend direction is still marked as bearish.
The company boasts an eye‑catching dividend yield of 13.25% but is generating negative earnings (trailing EPS –$0.08) and operating cash flow, raising serious questions about dividend sustainability. High 30‑day volatility (~48%) and a low beta (~0.55) indicate price swings that are not strongly tied to market moves, while a modest market cap and thin average volume point to liquidity constraints. Upcoming Q4/2025 results and a recent share repurchase announcement could add short‑term catalysts, but the fundamental picture remains challenged by declining revenue and negative margins.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish SMA positioning and overall trend
  • Positive MACD histogram hinting at possible short‑term bounce
  • Dividend yield appears unsustainable given negative cash flow

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential catalyst from upcoming earnings release
  • Continued revenue decline and negative operating margins
  • High dividend yield may attract income‑seeking investors despite risks

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Persistent losses, negative free cash flow, and weak ROE/ROA
  • Elevated volatility and liquidity constraints
  • Sector headwinds for internet retail and direct‑selling models

Key Metrics & Analysis

Financial Health

Revenue Growth-10.10%
Profit Margin-2.22%
ROE-3.13%
ROA-2.41%
Debt/Equity8.54
P/B Ratio1.5
Op. Cash Flow$-5997000
Free Cash Flow$-6088000

Technical Analysis

TrendBearish
RSI54.0
Support$2.66
Resistance$3.06
MA 20$2.83
MA 50$3.10
MA 200$3.78
MACDBullish
VolumeStable
Fear & Greed Index86.59

Valuation

GradeFair
TypeValue
Dividend Yield13.25%

Risk Assessment

Beta0.55
Volatility47.66%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.